163 related articles for article (PubMed ID: 28402278)
1. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients.
Hu J; Hu H; Hang JJ; Yang HY; Wang ZY; Wang L; Chen DH; Wang LW
Oncotarget; 2016 Nov; 7(48):78557-78565. PubMed ID: 27713167
[TBL] [Abstract][Full Text] [Related]
3. Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer.
Hu H; Han T; Zhuo M; Wu LL; Yuan C; Wu L; Lei W; Jiao F; Wang LW
Sci Rep; 2017 Mar; 7(1):470. PubMed ID: 28352075
[TBL] [Abstract][Full Text] [Related]
4. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion.
Lee JY; Lee KT; Lee JK; Lee KH; Jang KT; Heo JS; Choi SH; Kim Y; Rhee JC
Br J Cancer; 2011 Mar; 104(6):1027-37. PubMed ID: 21364590
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer.
Wang L; Guan X; Gong W; Yao J; Peng Z; Wei D; Wu TT; Huang S; Xie K
Clin Exp Metastasis; 2005; 22(3):205-13. PubMed ID: 16158248
[TBL] [Abstract][Full Text] [Related]
7. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
[TBL] [Abstract][Full Text] [Related]
8. Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma.
Hang J; Hu H; Huang J; Han T; Zhuo M; Zhou Y; Wang L; Wang Y; Jiao F; Wang L
Oncotarget; 2016 May; 7(19):28207-17. PubMed ID: 27057636
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 in pancreatic cancer and its significance.
Li XP; Zhang XW; Zheng LZ; Guo WJ
Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
[TBL] [Abstract][Full Text] [Related]
11. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer.
Niu Z; Wang M; Zhou L; Yao L; Liao Q; Zhao Y
Sci Rep; 2015 Nov; 5():16067. PubMed ID: 26530532
[TBL] [Abstract][Full Text] [Related]
12. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
Li BS; Liu H; Yang WL
Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
[TBL] [Abstract][Full Text] [Related]
13. Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer.
Wang W; Yin X; Li G; Yi J; Wang J
Chin Med J (Engl); 2014; 127(14):2637-42. PubMed ID: 25043081
[TBL] [Abstract][Full Text] [Related]
14. TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer.
Zhang Y; Jiang H; Qin M; Su X; Cao Z; Wang J
Tumour Biol; 2016 Jan; 37(1):1035-40. PubMed ID: 26269113
[TBL] [Abstract][Full Text] [Related]
15. FoxQ1 is a Novel Molecular Target for Pancreatic Cancer and is Associated with Poor Prognosis.
Zhan HX; Xu JW; Wang L; Wu D; Zhang GY; Hu SY
Curr Mol Med; 2015; 15(5):469-77. PubMed ID: 26122655
[TBL] [Abstract][Full Text] [Related]
16. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance.
Zhou L; Wang MY; Liang ZY; Zhou WX; You L; Pan BJ; Liao Q; Zhao YP
Hum Pathol; 2016 Oct; 56():171-7. PubMed ID: 27346572
[TBL] [Abstract][Full Text] [Related]
17. Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome.
Guan H; Cai J; Zhang N; Wu J; Yuan J; Li J; Li M
Int J Cancer; 2012 Feb; 130(3):593-601. PubMed ID: 21469139
[TBL] [Abstract][Full Text] [Related]
18. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
19. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Wang J; Zhang S; Wu J; Lu Z; Yang J; Wu H; Chen H; Lin B; Cao T
Mol Med Rep; 2017 Jul; 16(1):499-506. PubMed ID: 28586005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
